Unison Pharmaceuticals Pvt. Ltd.
Shalin Maghani is an experienced professional in international business development, specializing in the pharmaceutical sector. Currently serving as an Executive for International Business Development in Europe at Unison Pharmaceuticals Pvt. Ltd. since April 2023, Shalin previously held similar positions at Swiss Parenterals Ltd. and Cadila Pharmaceuticals Limited, showcasing a strong focus on European and Canadian markets. Shalin holds a Master of Business Administration with a concentration in Pharmaceutical Marketing and Management from Ganpat University, attained between 2021 and 2023, as well as a Bachelor's degree in Pharmacy from Nirma University, completed in 2020.
Unison Pharmaceuticals Pvt. Ltd.
2 followers
With almost four decades of medical service to the society, Unison Pharmaceuticals is an emerging global pharmaceutical company with strong identity in Indian market (Gujarat) and started spreading the wings in regulated and semi-regulated markets. Our vision of becoming a globally renowned company is supported by dedicated team of R&D scientists, pharmacists and state-of-an-art manufacturing facilities equipped with latest technologies. Our philosophy is to provide world class quality medicines at most affordable price to ensure the best healthcare possible. With our core competence in chronic segments; Anti-Hypertensives, Anti-Diabetics and Lipid-Lowering drugs, we have more than 165 products in the basket with presence in different therapeutic segments like; Anti-hypertensives, Anti-Diabetics, Lipid-lowering, Anti-Infective, Anti-biotics, Respiratory management, Hematinics, Anti-Allergics, Steroids, Psychotropics, Calcium and Vitamin Supplements and others.